MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-13-2026
Cytosorbents Corporation Total Non Current Liabilities 2011-2026 | CTSO
Annual Total Non Current Liabilities Cytosorbents Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 14 M | 9.27 M | 5.99 M | 4.08 M | - | - | 15.2 M | 12.9 M | 276 K | 1.08 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 15.2 M | 276 K | 7.86 M |
Quarterly Total Non Current Liabilities Cytosorbents Corporation
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 276 K | 276 K | 276 K | 276 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 276 K | 276 K | 276 K |
Total Non Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cutera
CUTR
|
430 M | - | -10.19 % | $ 1.99 M |  USA |
 |
EDAP TMS S.A.
EDAP
|
7.44 M | - | - | $ 162 M |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | USA |
 |
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | USA |
 |
Eargo
EAR
|
161 M | - | - | $ 10.2 M | USA |
 |
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
23.9 M | $ 13.59 | 1.57 % | $ 385 M | USA |
 |
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
89.9 M | $ 8.26 | 4.42 % | $ 1.24 B | USA |
 |
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | USA |
 |
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.12 | 0.9 % | $ 19 M | USA |
 |
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | USA |
 |
Helius Medical Technologies
HSDT
|
252 K | $ 1.48 | 7.25 % | $ 32.6 M | USA |
 |
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | USA |
 |
LivaNova PLC
LIVN
|
516 M | $ 77.17 | 3.17 % | $ 4.21 B |  Britain |
 |
Pulmonx Corporation
LUNG
|
25 M | $ 1.53 | 2.68 % | $ 62.2 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
116 M | $ 18.49 | 1.43 % | $ 434 M | USA |
 |
Delcath Systems
DCTH
|
2.52 M | $ 11.69 | 6.86 % | $ 419 M | USA |
 |
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
9.02 M | - | - | $ 111 M |  Canada |
 |
Orthofix Medical
OFIX
|
83.1 M | $ 9.87 | 1.86 % | $ 391 M |  Curacao |
 |
LENSAR
LNSR
|
3.44 M | $ 5.69 | 1.61 % | $ 68 M | USA |
 |
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
8.87 K | $ 36.29 | -2.13 % | $ 307 M | USA |
 |
MiMedx Group
MDXG
|
65.4 M | $ 3.71 | 0.27 % | $ 548 M | USA |
 |
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | USA |
 |
Myomo
MYO
|
275 K | $ 1.31 | 2.34 % | $ 54.8 M | USA |
 |
Globus Medical
GMED
|
18.2 M | $ 82.52 | 5.39 % | $ 11.2 B | USA |
 |
Insulet Corporation
PODD
|
1.06 B | $ 159.61 | 5.35 % | $ 11.2 B | USA |
 |
Profound Medical Corp.
PROF
|
2.44 M | $ 6.82 | 3.81 % | $ 206 M | Canada |
 |
CONMED Corporation
CNMD
|
877 M | $ 36.9 | 6.99 % | $ 1.15 B | USA |
 |
Inspire Medical Systems
INSP
|
24.6 M | $ 42.21 | 0.64 % | $ 1.24 B | USA |
 |
Integer Holdings Corporation
ITGR
|
1.02 B | $ 94.1 | 2.41 % | $ 3.27 B | USA |
 |
Invacare Corporation
IVC
|
325 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.44 B | $ 87.54 | 1.97 % | $ 51.2 B | USA |
 |
Sintx Technologies
SINT
|
1.76 M | $ 2.15 | 3.86 % | $ 5.96 M | USA |